JPY 330.0
(0.92%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 1.1 Billion | 1.83 Billion | 1.63 Billion | 23.61 Million | 1.19 Billion | -796.81 Million |
Net Income | 338.26 Million | 1.37 Billion | 1.03 Billion | 358.72 Million | 808.23 Million | 1.16 Billion |
Depreciation & Amortization | 521.5 Million | 500.02 Million | 440.58 Million | 422.91 Million | 458.84 Million | 447.03 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 568.79 Million | 385.65 Million | 272.2 Million | -852 Million | 696.13 Million | -1.66 Billion |
Other non-cash items | 526.41 Million | -424.66 Million | -112.92 Million | 93.98 Million | -770.87 Million | -741.38 Million |
Investing Cash Flow | -70.47 Million | -14.18 Million | 20.75 Million | 169 Million | -144.2 Million | -2.61 Billion |
Investments in PPE | -34.49 Million | -13.23 Million | -46.47 Million | -68.5 Million | -131.8 Million | -56.37 Million |
Acquisitions | - | - | - | 266.08 Million | - | -2.45 Billion |
Investment purchases | -30 Million | -10 Million | -50 Million | -60 Million | - | -80 Million |
Sales/Maturities of investments | - | - | - | -17.35 Million | - | -8.71 Million |
Other Investing Activities | -5.97 Million | 9.04 Million | 117.22 Million | 48.77 Million | -12.39 Million | -12.83 Million |
Financing Cash Flow | -960.92 Million | -957.33 Million | -951.54 Million | -329.56 Million | -903.25 Million | 3.28 Billion |
Debt repayment | -645.16 Million | -539.97 Million | -539.97 Million | -419.97 Million | -419.97 Million | -209.97 Million |
Dividends payments | -315.76 Million | -316.03 Million | -316.04 Million | -316.29 Million | -270.91 Million | -249.99 Million |
Common Stock Repurchased | - | - | - | -89 Thousand | - | -254.94 Million |
Common Stock Issuance | - | - | - | 406.79 Million | - | 3.99 Billion |
Other Financing Activities | -106 Million | -101.31 Million | -95.53 Million | -1000.00 | -212.36 Million | -3000.00 |
Accounts receivables | 195.46 Million | -413 Million | 126 Million | -848 Million | -474 Million | 300 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 373.32 Million | 798.65 Million | 146.2 Million | -4 Million | 1.17 Billion | -1.96 Billion |
Cash at beginning of period | 7.04 Billion | 5.98 Billion | 5.08 Billion | 5.21 Billion | 5.05 Billion | 5.17 Billion |
Cash at end of period | 7.46 Billion | 7.04 Billion | 5.98 Billion | 5.08 Billion | 5.21 Billion | 5.05 Billion |
Capital Expenditure | -34.49 Million | -13.23 Million | -46.47 Million | -68.5 Million | -131.8 Million | -56.37 Million |
Effect of forex changes on cash | 347.05 Million | 188.37 Million | 200.41 Million | 10.24 Million | 10.47 Million | 14.64 Million |
Net cash flow / Change in cash | 423.09 Million | 1.05 Billion | 901.41 Million | -126.7 Million | 155.35 Million | -117.51 Million |
Free Cash Flow | 1.07 Billion | 1.82 Billion | 1.58 Billion | -44.89 Million | 1.06 Billion | -853.18 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -82 Million | 85 Million | 338.26 Million | 75 Million | 175 Million | 3 Million |
Depreciation & Amortization | - | - | 521.5 Million | 130.75 Million | 134.66 Million | 120.2 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 568.79 Million | - | - | - |
Other non-cash items | 82 Million | -85 Million | 526.41 Million | -75 Million | -175 Million | -3 Million |
Investing Cash Flow | - | - | -70.47 Million | - | - | - |
Investments in PPE | - | - | -34.49 Million | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | -30 Million | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | -5.97 Million | - | - | - |
Financing Cash Flow | - | - | -960.92 Million | - | - | - |
Debt repayment | - | - | -645.16 Million | - | - | - |
Dividends payments | - | - | -315.76 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -106 Million | - | - | - |
Accounts receivables | - | - | 195.46 Million | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | 373.32 Million | - | - | - |
Cash at beginning of period | - | - | 7.04 Billion | 7.31 Billion | 6.26 Billion | 7.04 Billion |
Cash at end of period | - | - | 7.46 Billion | 7.34 Billion | 7.31 Billion | 6.26 Billion |
Capital Expenditure | - | - | -34.49 Million | - | - | - |
Effect of forex changes on cash | - | - | 347.05 Million | - | - | - |
Net cash flow / Change in cash | - | - | 423.09 Million | 25.02 Million | 1.05 Billion | -777.26 Million |
Free Cash Flow | - | - | 1.07 Billion | 261.51 Million | 269.33 Million | 240.4 Million |
601818
600284
300444
0288
CANDOUR
OMIC